News

June 19, 2018

PTC Therapeutics Announces Risdiplam (RG7916) is Well Tolerated at All Dose Levels With No Drug-Related Safety Findings

On Saturday, PTC Therapeutics, Inc. announced the presentation of updated interim clinical data from Part 1 of the FIREFISH study investigating risdiplam (RG7916) in babies with Type 1 Spinal Muscular Atrophy...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

June 16, 2018

Cytokinetics Presents Data from the Phase 2 Clinical Trial of Reldesemtiv (CK-2127107) in Patients with SMA at the 2018 Annual SMA Conference

Cytokinetics Presents Data from the Phase 2 Clinical Trial of Reldesemtiv (CK-2127107) in Patients with SMA at the 2018 Annual SMA Conference

Today, Cytokinetics announced data from the Phase 2 clinical study of reldesemtiv in patients with SMA, presented in an oral presentation by...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

June 14, 2018

Biogen to Present New Data at the 2018 Annual SMA Conference

Biogen to Present New Data at the 2018 Annual SMA Conference

Yesterday, Biogen announced it will present data from its SPINRAZA clinical development program –the largest of its kind, with more than six years of...

READ MORE   |  

Topics: Conference, Research, Front Page News

June 12, 2018

The 2018 Annual SMA Conference is Here!

The 2018 Annual SMA Conference is Here!

The 2018 Annual SMA Conference, now in its 30th year, is set to kick off on June 14 and continue into a weekend full of programs and events that bring families, researchers and healthcare professionals together.

This year’s conference will be the largest in the Midwest to date....

READ MORE   |  

Topics: Conference, Front Page News

June 12, 2018

Thank You to Our 2018 Annual SMA Conference Sponsors!

Thank you to the following sponsors who are generously supporting the 2018 Annual SMA Conference. This one-of-a-kind event would not be possible without your support!

For more information about the below companies, please visit our conference sponsor...

READ MORE   |  

Topics: Conference, Front Page News

June 11, 2018

Thank You to Our 2018 Annual SMA Conference Exhibitors!

Thank you to the following exhibitors who are generously supporting the 2018 Annual SMA Conference. This incredible and unique event would not be possible without your support! 

For more information on any of the below companies, please visit our

READ MORE   |  

Topics: Conference, Front Page News

June 7, 2018

Traveling with SMA

Traveling with SMA

As the summer season nears, many families will make plans to travel across the country to exciting destinations or to spend time with those they love. This is no different for those affected by SMA.

Although travel can present challenges, regardless of distance or method chosen, below...

READ MORE   |  

Topics: Community & Awareness, About SMA, Front Page News

June 1, 2018

Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015

Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015

Scholar Rock, a biotechnology company based in Boston, recently announced that it has completed dosing of the first cohort and is continuing...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

May 31, 2018

Ohio Moves One Step Closer to SMA Newborn Screening

Ohio Moves One Step Closer to SMA Newborn Screening

The Ohio Newborn Screening Advisory Committee recommended that SMA be added to their state’s newborn screening panel. The recommendation now goes to the Ohio Department of Health for a rulemaking process. Once these rules are developed and approved, SMA will be officially added to the...

READ MORE   |  

Topics: Our Impact, Advocacy, Front Page News

May 30, 2018

Roche Releases Community Statement on Olesoxime Program

Roche Releases Community Statement on Olesoxime Program

Roche today provided the following community statement on olesoxime.

Dear members of the SMA Community,

We would like to provide you with an update about olesoxime, an investigational molecule in SMA.

Since we bought olesoxime from Trophos in 2015, we have had many...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

Items 1 - 10 of 444  12345678910Next

© 2018 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software